Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, but growth may accelerate after 2026. Read more here.

It was wild and so hard to describe, but think about being near a stream ... healthy for me and my family, and not gain back what I lost.” Personal testimonials about GLP-1 agonists show the ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of ... That result sparked a near-5% increase in Roche's share price, and the latest announcement had ...

These drugs are known as GLP-1 agonists. GLP-1 is a naturally ... dates back to when Ron Jaworski was still allowed near a microphone. I’m only bringing up Chuck’s gripe here because it dawned on me, ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Only a tiny percentage of people addicted to alcohol or drugs take medication for it. Why not? It's complicated, but the approved medications are not blockbusters for alcohol use disorder.

DeBenedetto, now 43, tells me she's been prediabetic since her 20s ... drug whose miracle will no longer be easily accessible. GLP-1 drugs such as semaglutide and tirzepatide are at the center ...

"They say, 'Tell me what you're taking,' and I'm like ... Doctors on staff can prescribe supplements and medications, including GLP-1 drugs for weight loss. "You come in, we take your blood ...

At the same time, concerns about GLP-1 weight loss drugs have exacerbated ... and this is the chart that is giving me confidence," Batnick said in a podcast this week for The Compound.